What's Eleotin®? Who's EBMR? Eleotin® Pamphlet  Research for Type I DiabeticsMore Info about Eleotin® Order Eleotin®

What's Eleotin®?

ELEOTIN® is a safe health food that restores the body's own ability to control blood glucose levels. ELEOTIN® gently helps to control blood glucose levels temporarily but also results in long-term molecular level changes assist the body to recover glucose normalcy. ELEOTIN®'s usage may then be diminished or eliminated as the body has restored its ability to control blood glucose levels.

ELEOTIN® is a food product that we believe is more beneficial than existing hypoglycaemic drugs.

For some people, this answer is difficult to believe. They find it difficult to believe that a serious disease can be treated more effectively with a "Gentle & Safe" food product when existing "Super-Strong" drug treatments. What we believe is that correct use of a gentle food or herbal combination is much better than the use of strong, intrusive chemical drugs that harmfully target certain organs. This principle is especially true for serious diseases that affect many parts of the body.

What our body needs in this case is not a strong stimulus but a proper balance.  The strong stimulus that drugs provide usually has a positive short-term effect. But drugs in the long-term can cause drug resistance and lead to numerous negative side effects. We feel a proper treatment would be one that helps all the internal organs and inner mechanisms to function better by restoring balance to a body that has lost its rhythm, and its own ability to heal itself. The body can heal itself of most diseases and in many cases, the only thing we have to do is to trigger this self-healing ability. In order to trigger this self-healing ability, we do not need strong chemical signals. Thus the gentle, mild signaling herbs contained in ELEOTIN® often produce a much more beneficial result.

The same principle is true for diabetes.  Overall, curative actions in our body should occur simultaneously and in harmony for treatment of diabetes to be successful for a long period of time.  The existing drug treatments for diabetes have their limits even though they have demonstrated certain short-term strengths.  Diabetic drugs have an effect on only one or two metabolic processes and are not able to help the complex metabolism associated with diabetes as a whole. Because of their concentrated focus, chemical drugs also put a serious strain on the body due to the drug's cumulative toxicity. They often cause or contribute to permanent damages of these organs, which may be even worse than the damage caused by diabetes itself.

In conclusion, we believe that natural foods are far more advantageous for diabetes than chemical drugs.  Chemical drugs provide only temporary glucose control and in the long-term may cause severe damage to a person's liver and kidneys because of their concentrated and toxic chemical actions.  We strongly recommend that people use food products or herbal combinations that are gentle and safe as their first and best line of defense. ELEOTIN® offers this. We feel that ELEOTIN® is the most scientifically superior herbal combination presently on the market.
 

ELEOTIN® contains dried roots, stems, fruits, and leaves, from various plants.  The herbal plants are all registered with pharmacopoeias and food codes in several countries. All of the material used is 100% natural and we do not add any fillers or preservatives.

The ingredients for the various blends are listed on each ELEOTIN® box. The ingredients are Platycodi Radix (Root), Schizandrae Fructus (Fruit), Capsella Bursa (Stem), Glycyrrhizae Radix (Root), Astragalus Membranaceus Bunge (Root), Lycium Chinese (Fruit), Dioscorea Japonica Thunberg (Root) and others.

ELEOTIN® was initially developed by the scientists at Diabetes Research Center at the University of Calgary, Calgary Alberta, Canada, a leader in the research on the cause, cure, and prevention of Type 1 and Type 2 diabetes.

Who's EBMR?

Eastwood Bio-Medical Research Inc. (EBMR) is a privately owned Canadian company
engaged in the development and commercialization of safe and effective treatment
for non-insulin dependent diabetes mellitus (NIDDM-Type II diabetes) and cancer.
EBMR's core technologies include the NIDDM treatment, known as ELEOTIN®,
and a recently discovered therapy for the treatment of stomach cancer,
referred to as Gamma-C 200.

Incorporated in 1996, Dr. Youngsoo Kim is EBMR's Chief Executive Officer as well as a major
shareholder. Dr. Kim is a scholar in the area of international finance and has served
as a senior official in the Government of Korea.

Located in Vancouver, EBMR is currently commercializing a patented 100% natural herbal
treatment for controlling and regulating blood glucose levels. Initially developed at the Julia McFarlane Diabetes Research Centre,
ELEOTIN®has undergone numerous tests involving both animal and human subjects
in various research facilities.
ELEOTIN® has been proven to be safe and effective in the improvement
of blood glucose levels in NIDDM patients.
It is composed of the extract of several medicinal plants,
each playing a synergistic role in ELEOTIN®'s mechanism of action.
Furthermore, ELEOTIN® supports a part of Yale University's Program
for Basic Diabetes Research.

Since ELEOTIN®is composed exclusively from natural herbs, it is sold
as a dietary supplement and does not require a prescription.
As a supplement to a well-balanced diet,
users have reported an improvement in general health.
ELEOTIN® is now available for public consumption.

In addition to ELEOTIN®, EBMR is working on developing
a new treatment approach for stomach cancer.
Gamma C-200 refers to an aqueous extract from plant
which has shown a specific and distinct effect on the inhibition or suppression
of gastric tumor cell growth in vitro and in vivo, but not on normal cells.
Our current stage of research will involve the identification and isolation of
active chemical components and the confirmation of biological and pharmacological activity.
Following the completion of this stage, Gamma C-200 will be ready to enter preclinical trials.

Eastwood Bio-Medical Research Inc. will continue to explore advances in biotechnology
and be an innovative leader in the fight against diabetes, cancer, and other related complications.
 

Back to Top

Eleotin® Pamphlet

Click below to review ELEOTIN®'s product brochure

Disclaimer : Eleotin is classified as a health food in the U.S and Canada. We make no claims, either expressed or implied, that this product will cure disease, replace prescription medication, or supersede sound medical advice.

Back to Top

Research for Type I Diabetics

Back to Top